Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Asset disposition Appointed CFO Quarterly results Acq. announced Director departure CC transcript
|
MGI PHARMA INC (MOGN)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/12/2007 |
8-K/A
| Cost Associated with Exit or Disposal Activities |
02/09/2006 |
8-K/A
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
11/07/2005 |
8-K/A
| Financial Statements and Exhibits
Docs:
|
"Consent of KPMG LLP",
"Audited consolidated financial statements of Guilford, including Guilford's consolidated balance sheets as of December 31, 2004 and 2003, the consolidated statements of operations, changes in stockholders' equity and cash flows for each of the years in the three year period ended December 31, 2004",
"Unaudited condensed consolidated financial statements of Guilford, including Guilford's consolidated balance sheet as of June 30, 2005, the consolidated statements of operations, changes in stockholders' equity and cash flows for the six month period ended June 30, 2005",
"Unaudited pro forma condensed combined financial statements of the Company as of and for the six months ended June 30, 2005 and for the year ended December 31, 2004" |
|
12/14/2004 |
8-K/A
| Financial Statements and Exhibits |
11/19/2004 |
8-K/A
| Financial Statements and Exhibits |
08/27/2004 |
8-K/A
| Other Events, Financial Statements and Exhibits |
02/05/2001 |
8-K/A
| Financial statements and exhibits |
|
|